News | March 29, 2022
USFDA approves EUA for second booster dose of Moderna
50 µg dose approved for all adults over 50 years of age and immunocompromised adults over 18 years of age
50 µg dose approved for all adults over 50 years of age and immunocompromised adults over 18 years of age
New collaboration will help customers reach sustainability goals for high-performance Udel PSU polymers in demanding applications.
Under the agreement, Technology Development Board and Bharat Biotech have pledged the support of Rs.200 crore each to create a continuous corpus of Rs.400 crores for the project
Launched in the year 2018, MedEngage Scholarship Program is aimed at nurturing and nourishing medical talent in India
In May 2021, Daiichi Sankyo had submitted a supplemental new drug application (sNDA) for Tarlige tablets based on results from a phase 3 trial in patients with CNP
This targeted capacity-building and advocacy project in 15 districts and 5 states of India has facilitated the certification of disability for 11,152 people, provided disability pensions to 8,144 people and supported the issuing of voter IDs to 8,450 people with disabilities
Clinical trials for minimally invasive therapy procedures using advanced imaging from Philips Lung Suite start with successful first cases
Registration is open for the global event that invites technology enthusiasts to bring innovative ideas to improve healthcare outcomes
Veritaz has over 40 brands marketed across the acute and critical care therapeutic segments
The MoU proposed investments in hospitals, pharmacies and laboratories in the state
Subscribe To Our Newsletter & Stay Updated
